ClinicalTrialsFinder

Blasts More Than 5 Percent of Bone Marrow Nucleated Cells Clinical Trials in Sacramento, California

1 recruitingSacramento, California

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction

Refractory Acute Myeloid LeukemiaBlasts More Than 5 Percent of Bone Marrow Nucleated CellsPersistent Disease
Ohio State University Comprehensive Cancer Center28 enrolled2 locationsNCT04049539